Corticosteroid use in small animal neurology

Area of Science:

• Veterinary Neurology
• Pharmacology

Background:

• Glucocorticoids are commonly prescribed by veterinarians for central nervous system (CNS) diseases.
• Their use is often non-specific and lacks strong clinical justification.

Purpose of the Study:

• To evaluate the appropriateness and consequences of using glucocorticoids for CNS diseases in veterinary medicine.
• To highlight the potential negative impacts on diagnostics and treatment adherence.

Main Methods:

• Review of current veterinary practices regarding glucocorticoid use in CNS disease.
• Analysis of the impact of glucocorticoids on diagnostic procedures (e.g., MRI, CSF analysis).
• Assessment of owner perception and treatment abandonment related to glucocorticoid therapy.

Main Results:

• Glucocorticoid use is infrequently the preferred or definitive treatment for CNS diseases.
• These drugs can interfere with diagnostic tests, altering findings like MRI appearance and cerebrospinal fluid cell counts.
• Owners may discontinue pursuit of appropriate therapies if initial glucocorticoid treatment appears ineffective.

Conclusions:

• The non-specific use of glucocorticoids in veterinary neurology is often unwarranted.
• This practice can compromise diagnostic accuracy and negatively affect patient outcomes by delaying or deterring definitive treatment.
• Veterinarians should exercise caution and consider alternative, evidence-based treatments for CNS conditions.